RHI Magnesita (RHIM)
CyclicalFairStock Score: 48/100 — MIXED
Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹379.85 |
| Market Cap | ₹7,843.96 Cr |
| P/E Ratio | 52.38 |
| ROCE | 7.06% |
| ROE | 4.29% |
| Dividend Yield | 0.66% |
| Profit Growth | 68% |
| Debt/Equity | 0.13 |
| Sales Growth | 7.97% |
| Free Cash Flow | ₹259.78 Cr |
| Promoter Holding | 56.07% |
| 52-Week Range | ₹323.05 — ₹508.3 |
| Sector | Industrial Products |
| Book Value | ₹172.42 |
Strengths
- Low debt/equity of 0.09 provides strong balance sheet resilience
- Positive free cash flow of ₹260 Cr supports self-funding and flexibility
- Piotroski F-Score of 8/9 indicates solid earnings quality and financial health
- Promoter holding of 56.07% aligns management with minority shareholders
- Profit growth of 29.49% shows improving near-term earnings momentum
Concerns
- Rich valuation with P/E of 52.38 and EV/EBITDA of 57.86 leaves little room for error
- ROE of 4.29% and ROCE of 7.06% are weak for the price paid
- Graham Number of ₹197.69 implies negative margin of safety at current price of ₹407.05
- Dividend yield of 0.58% offers negligible income while waiting for growth
AI Analysis
Let me look at RHI Magnesita with the same yardstick I'd use for any business. First, what does it give me? A clean balance sheet—debt/equity of 0.09—and free cash flow of ₹260 crore. The Piotroski score of 8 out of 9 tells me financial health is genuine, and promoter holding of 56% means owners are still in the game alongside me. But my next question is always: what returns does the business earn on the capital it uses? Here I'm troubled. ROE of 4.29% and ROCE of 7.06% are modest. This is not a wonderful compounder; it is a business earning a pedestrian return on assets. The ₹407 price translates into a P/E of 52.38 and EV/EBITDA of 57.86. Even the DCF estimate of ₹673.47 assumes a long runway of growth, but Graham would refuse to pay such prices unless certainty existed. The Graham Number of ₹197.69, a conservative anchor, is barely half the market price. Margin of safety is negative. Sales grew 8.27% and profit grew 29.49% in the latest year, but refractories are tied to the steel cycle; today's growth can vanish when industry demand cools. Dividend yield of 0.58% is poor. So do I buy? No. This is a financially sound, cyclical business with improving near-term momentum, but at 52 times earnings I am being asked to pay for perfection. I prefer to wait for a margin of safety, when price gives me more than the balance sheet and earnings power can justify. In the meantime, I'll watch how management deploys its ₹260 crore free cash flow.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer